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Abstract
Background: Despite international efforts to prevent hepatitis B virus (HBV) infection through
global vaccination programs, new cases are still being reported throughout the world.
Methods:  To supply data that might assist in improving preventive measures and national
surveillance for HBV infection, a cross-sectional study was conducted among individuals referred
to the Brazilian National Reference Center for Viral Hepatitis (Rio de Janeiro) during a two-year
period. Reported risk factors among infected subjects ("HBV-positive") were compared to those
of subjects never exposed ("HBV-negative") to HBV. Two subgroups were further identified within
the HBV-positive group, "acute" infection and "non-acute" infection.
Results: A total of 1,539 subjects were tested for HBV, of which 616 were HBV-positive (79 acute
infection and 537 non-acute infection). HBV-positive subjects were more likely to be of male
gender (63% versus 47%); and to report multiple sexual partners (12% versus 6%) and illicit drug
use (IDU and/or intranasal cocaine use) (6% versus 3%). Among the HBV-positive subgroups, age
differed significantly, with 48% being under 30 years of age in subjects acutely infected compared
to 17% in those with non-acute infection.
Conclusions: The association of multiple sexual partners with past HBV infection and the age
distribution of currently infected subjects suggest that sexual transmission played a major role in
the transmission of HBV in this study population. Thus, vaccination during adolescence should be
considered.
Background
Hepatitis B, a global but preventable disease, is estimated
to affect at least 300 million individuals throughout the
world. National vaccination programs have been encour-
aged since 1989 [1], and many countries have already
shown the impact of these programs in preventing chron-
ic hepatitis B virus (HBV) infection, and consequently
hepatocellular carcinoma [2–4], as well as their possible
cost effectiveness [5,6]. Not all countries, however, have
been able to implement hepatitis B vaccination on a na-
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tional level, and only in 1998 has it been included in Bra-
zil's national infant immunization calendar. In 1997, the
Brazilian National Reference Center for Viral Hepatitis
(BNRCVH), located in the coastal Southeastern region of
Brazil (Rio de Janeiro), established a patient referral site in
response to the gradual increase of referred individuals
from public and private hospitals and clinics, and blood
banks. The referral site has been engaged in diagnostic
testing for viral hepatitis, obtaining data from epidemio-
logic questionnaires, and tracking partners and house-
hold members at risk of hepatitis infection since its
establishment. In the present paper, major risk factors of
HBV infection are described based on subjects seen at the
BNRCVH, with the objective of providing data that might
help to improve preventive measures and national surveil-
lance.
Methods
Study population
The study population consisted of all subjects registered at
the BNRCVH's patient referral site between September
1997 and September 1999, who were tested for HBV sero-
logical markers. Interviewers used standardized question-
naires to obtain data on demographic characteristics and
risk factors for parenteral and sexual exposure to HBV. Ten
risk factors queried in the questionnaire were selected for
analysis and included history of: blood transfusion, sur-
gery, hemodialysis, occupation as a health professional,
intravenous drug use (IDU), intranasal cocaine use, tat-
toos, sexually transmitted diseases (STD), multiple sexual
partners (more than five sexual partners/year), and male
homosexuality.
Demographic variables such as gender, age, educational
and economic status, and residency were also assessed.
Age was categorized by decades into eight groups, with the
youngest group being under eleven years and the oldest
group over 60 years. Educational status was categorized
into two groups: those that were illiterate or had at most
completed primary education and those who had studied
beyond primary school. Economic status also was catego-
rized into two groups: individuals with a monthly income
of less than three minimum Brazilian salaries, which is
equivalent to approximately U$ 225, and those with high-
er wages. Residency was dichotomised as those living in
the mostly densely populated region of Rio de Janeiro
County (northern region) and those living elsewhere.
Laboratory testing
Testing for present or past HBV infection included hepati-
tis B surface antigen (HBsAg), antibody to HBsAg (anti-
HBs), antibodies to hepatitis B core (IgM anti-HBc, total
anti-HBc), hepatitis B e antigen (HBeAg), and antibody to
HBeAg (anti-HBe) (Organon Teknika, Boxtel, The Nether-
lands; and Bio-Manguinhos, FIOCRUZ, Brazil). Testing of
alanine aminotransferase (ALT) levels was also per-
formed.
HBV infection status: groups and subgroups
To evaluate the potential risk factors in subjects with dif-
ferent HBV infection status, individuals were categorized
into two groups, HBV-positive and HBV-negative groups.
The HBV-positive group was comprised of subjects who
tested positive for any HBV marker and the HBV-negative
group tested negative for all markers. Individuals who had
isolated anti-HBs were excluded since it may represent
hepatitis B vaccine response. To identify current trends in
transmission routes of HBV infection the HBV-positive
group was subsequently divided into two subgroups:
those with acute HBV infection and those with non-acute
HBV infection. The acute infection subgroup included in-
dividuals with present infection, who tested positive for
IgM anti-HBc with or without HBsAg. The non-acute in-
fection subgroup comprised of subjects with chronic or
past infection who were negative for IgM anti-HBc.
Chronic infection was confirmed by HBsAg positivity and
past infection with anti-HBc. Subjects with clinical symp-
toms (i.e., jaundice, choluria) were classified as sympto-
matic, and those with very mild or no symptoms were
considered asymptomatic.
Statistical analysis
Mean values for age and median values for ALT (non-nor-
mal distribution) were compared between the HBV
groups using the t-test and the Kruskal-Wallis test, as ap-
propriate. The Chi-square test was used to evaluate gender
distribution differences. To assess the association between
risk factors and HBV infection status, a multivariate anal-
ysis was used to adjust for age (continuous) and gender.
The adjusted prevalence ratios were estimated through a
binomial regression model using the log-link function in
STATA 6 (Stata Corporation, College Station, Texas) [7].
Results
Demographics
During these two years (1997 – 1999), the BNRCVH reg-
istered 1,539 subjects who were tested for HBV infection.
The mean age of these subjects was 38 years (range: 19
days – 86 years). Almost 67 percent had at most a primary
school education, and 55 percent received a monthly in-
come of less than three minimum salaries. Most subjects
living in Rio de Janeiro County were from the highly pop-
ulated area located in the northern region, and those from
other counties lived mostly in neighbourhood counties
that bordered this region. Among the 1,539 subjects eval-
uated, 616 (40%) were HBV-positive and 923 (60%) were
HBV-negative. Both groups shared similar referral profiles
with liver disease being the most predominant motive. In
the HBV-positive group, 79 (13%) had acute infection
and 537 (87%) had non-acute infection.BMC Public Health 2002, 2 http://www.biomedcentral.com/1471-2458/2/26
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The mean ages for the HBV-positive and the HBV-negative
groups did not differ significantly and were 42 and 37, re-
spectively. The mean ages for the HBV-positive subgroups
were 32 for acute infection and 43 for non-acute infection
(P < 0.0001). Table 1 summarizes age distribution among
individuals infected with HBV according to their different
infection status (acute infection versus non-acute infec-
tion).
Acute HBV infection
Seventy nine subjects were acutely infected with HBV, 52
males (66%) and 27 females (34%), with an average age
of 32 (± 14). Among the cases of acute hepatitis, 77% (61/
79) were symptomatic with the remaining detected during
family tracking. HBsAg was absent in 17/79 (22%) with
IgM anti-HBc as the only indicator of active infection on
at least two different samples tested.
Risk factors
Differences in the distribution of risk factors were com-
pared between the HBV-positive and -negative groups,
with similarities observed for educational level, economic
status, and residency (table 2). Higher frequencies were
observed in the HBV-positive group for history of blood
transfusion (15% versus 14%), surgery (40% versus
37%), hemodialysis (9% versus 8%), IDU (1% versus
0.5%), intranasal cocaine use (5% versus 3%), tattooing
(4% versus 3%), STD (10% versus 7%), multiple sexual
partners (12% versus 6%), and homosexuality (3% versus
2%). Adjusted prevalence ratios (table 2) demonstrated
HBV-positivity to be associated with history of multiple
partners when compared to the HBV-negative group. Al-
though the associations between IDU and intranasal co-
caine use and HBV-positivity were not statistically
significant, a significant association was obtained when
pooling these two variables in the analysis (PR = 1.8, 95%
CI 1.1 – 3.0, p = 0.04).
Risk factors compared between the acute and non-acute
HBV infection subgroups were similar (data not shown).
Sexual or household contact was reported in 26 (33%)
subjects with acute infection. Other routes of transmis-
sion reported among those acutely infected were: intrana-
sal cocaine use (8%), being a hemodialysis patient (5%),
and being a health professional without previous vaccina-
tion (5%).
Discussion
Brazil, the fifth largest country in the world, is divided
into five geographic regions which carry different endemic
patterns for HBV infection with a prevalence increasing
from south to north [8]. The Southeast region occupies
only 11% of the national territory but nevertheless, 43%
of the population, and has a low endemic pattern for HBV
infection [9,10]. In low-risk areas the highest incidence of
HBV infection is observed in adolescents and young
adults, while in more endemic areas most infections occur
in children. In the present study, the significant age differ-
ence observed between the acute and non-acute HBV in-
fection subgroups, suggests the low endemic pattern in
which adolescents and young adults have a lower frequen-
cy of HBV antibodies and are more prone to infection via
sexual activity and high-risk behaviours such as drug use.
In 1996, the highest number of HBV cases notified to the
Brazilian National Health Foundation was between the
ages 20 and 49 years [11]. An identical age distribution
was observed at the BNRCVH among subjects acutely in-
fected with HBV, with the highest numbers occurring in
the age groups 21 to 50 years. Multiple sexual partners or
history of STD was not uncommonly reported (22%) in
Table 1: Distribution of HBV infection according to age and clinical status
Age Category (years) Acute Non-Acute
Chronic Past Infection
n% n % n %
< 1–10 7 8.9 7 4.8 7 1.8
11–20 9 11.4 5 3.4 5 1.3
2 1 – 3 0 2 2 2 7 . 82 51 7 . 14 21 0 . 7
3 1 – 4 0 1 4 1 7 . 74 12 8 . 18 92 2 . 8
4 1 – 5 0 1 6 2 0 . 23 32 2 . 69 92 3 . 3
5 1 – 6 0 7 8 . 8 2 21 5 . 17 11 6 . 2
> 60 2 2.5 9 6.2 56 14.3
Unknown 2 2.5 4 2.7 22 5.6
Total 79 100.0 146 100.0 391 100.0BMC Public Health 2002, 2 http://www.biomedcentral.com/1471-2458/2/26
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these age groups, which suggests a role for sexual trans-
mission of HBV in this population. Even though fewer
cases of current infection were observed in subjects in the
11 to 20 age category, they had a higher proportion (64%)
of acute cases when compared to older age groups, whose
proportions ranged from 18% to 46%.
Male gender also seemed to play an important role in the
acquisition of HBV infection. There were approximately
twice as many males as females with acute HBV infection.
Previous studies have demonstrated that men are more
likely to become chronic HBV carriers than women [12].
However, the gender difference in the acute cases might
also reflect the increased frequency of high-risk behavior,
such as multiple sexual partners and drug use among men
compared to women.
The lack of association observed with IDU and HBV infec-
tion may have been due to under reporting. Intranasal use
of cocaine alone may be a transmission route since it is
not uncommon for a few to have reported nasal bleeding
following the procedure.
Even though the study was not population-based our
findings are in accordance with published data, such as
having multiple sex partners and illicit drug use [13–16].
Due to the high concentration of circulating HBV and the
virus's ability to remain viable on environmental surfaces
for more than a week [17], hemodialysis patients are espe-
cially at high risk of acquiring HBV infection. This was
demonstrated again in this study where even though most
of our hemodialysis patients with documented HBV infec-
tion were chronic carriers, four were acutely infected. The
continued association between hemodialysis and HBV in-
fection suggests that some hemodialysis facilities have
failed to completely implement the recommended infec-
tion control measures. Sporadic outbreaks are still being
and will continue to be reported in these facilities [18].
Conclusions
In summary, the age categories in which most new cases
of HBV infection occurred together with the associations
observed between multiple sexual partners and HBV in-
fection strongly suggest that unsafe sexual behavior plays
a major role in transmitting HBV infection in this study
group. Moreover, since hemodialysis facilities may still be
hazardous environments for acquiring blood-borne dis-
eases, infection control practices should be intensified
jointly with continuous education of health-care workers.
The results from this study also support the extension of
HBV vaccination to early adolescence to prevent sexual
transmission.
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